Latest News

 Filter by Provider

uniQure NV reports mixed Q2 2025 results with revenue missing estimates but EPS beating forecasts. Shares rise on regulatory progress for Huntington's gene therapy AMT-130.

The USD/CHF rallied sharply following the US-EU trade agreement, but a daily close above 0.81 is needed to confirm a breakout from the current consolidation zone.

A deeper decline is coming this quarter. Speculating that some weakness this month could see a quick decline to the 6200 area. ​​​​​​​

Freight transportation company Norfolk Southern (NYSE:NSC) missed Wall Street’s revenue expectations in Q2 CY2025 as sales rose 2.2% year on year to $3.11 billion. Its GAAP profit of $3.41 per share was 3.3% above analysts’ consensus estimates.

Climb stock is up over 240% since mid-2023, Adhishthana principles show a classic Phase 9 breakout. Here's what investors need to know next.

Visa currently offers a dividend yield of 0.66%, about $2.36 annually. How can investors pocket a regular $500 monthly?

Data backup provider Commvault (NASDAQ:CVLT) reported Q2 CY2025 results beating Wall Street’s revenue expectations, with sales up 25.5% year on year to $282 million. Guidance for next quarter’s revenue was better than expected at $273 million at the midpoint, 0.7% above analysts’ estimates. Its non-GAAP profit of $1.01 per share was 4.1% above analysts’ consensus estimates.

Palantir stock fell on Monday amid a report the government is evaluating Microsoft's artificial intelligence models. Shares rose Tuesday.

Merck's second-quarter performance showed a slight decline in sales compared to the previous year.

Biopharma manufacturing company Repligen Corporation (NASDAQ:RGEN) reported Q2 CY2025 results beating Wall Street’s revenue expectations, with sales up 14.8% year on year to $182.4 million. The company’s full-year revenue guidance of $725 million at the midpoint came in 2.1% above analysts’ estimates. Its non-GAAP profit of $0.37 per share was 5% below analysts’ consensus estimates.

Spotify's Q3 2025 financial results disappoint investors despite strong user growth and improved profitability. Stock price declines after earnings miss and conservative outlook.

Electrical and electronic products company Hubbell (NYSE:HUBB) missed Wall Street’s revenue expectations in Q2 CY2025 as sales rose 2.2% year on year to $1.48 billion. Its non-GAAP profit of $4.93 per share was 12.1% above analysts’ consensus estimates.

According to Glassnode data, net inflows into ETFs are down 80% to $496 million, and trade volume has dropped to $18.7 million over the past week.

Glass and electronic component manufacturer Corning (NYSE:GLW) met Wall Street’s revenue expectations in Q2 CY2025, with sales up 18.8% year on year to $3.86 billion. The company expects next quarter’s revenue to be around $4.2 billion, coming in 4.2% above analysts’ estimates. Its non-GAAP profit of $0.60 per share was 5.1% above analysts’ consensus estimates.

This year I'm planning to max out my 401(k) contributions. Here's why it's the smartest, simplest investment move I can make right now.

On Monday, silver prices remained under pressure, staying below $38.50 per ounce after falling more than 2% in the previous session, as recent trade deals between the US and key partners reduced demand for safe-haven assets.

Oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) missed Wall Street’s revenue expectations in Q2 CY2025, but sales rose 10.2% year on year to $181.3 million. The company’s full-year revenue guidance of $723 million at the midpoint came in 2.9% below analysts’ estimates. Its non-GAAP profit of $0.03 per share was in line with analysts’ consensus estimates.

Cramer looks at Brighthouse Financial, Hecla Mining, Universal Technical Institute, and Grindr, which all closed lower on Monday.

Communications platform-as-a-service company Bandwidth (NASDAQ: BAND) reported Q2 CY2025 results exceeding the market’s revenue expectations, with sales up 3.7% year on year to $180 million. On the other hand, next quarter’s revenue guidance of $190 million was less impressive, coming in 1.1% below analysts’ estimates. Its non-GAAP profit of $0.38 per share was 14% above analysts’ consensus estimates.

Biopharmaceutical company Incyte Corporation (NASDAQ:INCY) announced better-than-expected revenue in Q2 CY2025, with sales up 16.5% year on year to $1.22 billion. Its non-GAAP profit of $1.57 per share was 6.5% above analysts’ consensus estimates.

Aerospace and defense company Boeing (NYSE:BA) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 34.9% year on year to $22.75 billion. Its non-GAAP loss of $1.24 per share was 5.5% above analysts’ consensus estimates.

While Dow Jones futures were up 0.09% at the time of writing, the S&P 500 futures surged 0.26%.

It's worth taking the time to learn about a company whose shares have historically crushed the market.

Quantitative trading based on market sentiment is a less developed area compared to traditional approaches.

The health insurer said that the company expects to return to earnings growth in 2026.

Cadence experienced a 3,400% explosion in Stocktwits user message count in the last 24 hours after better-than-expected Q2 earnings.

Catalyst Pharmaceuticals (CPRX) is a value stock with strong fundamentals—low P/E, zero debt, high profitability, and robust growth, making it a standout in biotech.

As Kalshi and Polymarket achieve Unicorn status, markets are betting on blockchain to make future-gazing investable.

Consumer products behemoth Proctor & Gamble (NYSE:PG) met Wall Street’s revenue expectations in Q2 CY2025, with sales up 1.7% year on year to $20.89 billion. Its non-GAAP profit of $1.48 per share was 4.1% above analysts’ consensus estimates.

EPS and revenue gains accelerated again. The fintech also raised 2025 revenue targets.

Crypto mining hardware producer Bitmain Technologies is preparing to establish its first U.S. facility later this year, a move influenced by shifting industrial policies and a growing "Made in America" sentiment within the digital asset sector.

UPS offers a high 6.4% dividend yield with strong growth, backed by solid profitability and reasonable valuation, making it a compelling pick for income-focused investors.

Palantir's share price continues rocketing higher. But Nvidia and Taiwan Semiconductor could be better buys right now.

Palantir is emerging as the AI backbone of U.S. defense, with key contracts and real-world deployments driving growth ahead of earnings